No photo of Cezary Wojcik

View Scopus Profile

Cezary Wojcik

Assistant Professor

  • 2159 Citations
  • 24 h-Index
19952019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Cezary Wojcik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Proteasome Endopeptidase Complex Medicine & Life Sciences
Ubiquitin Medicine & Life Sciences
Proteasome Inhibitors Medicine & Life Sciences
Proteolysis Medicine & Life Sciences
Chymotrypsin Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
HeLa Cells Medicine & Life Sciences
Cathepsin A Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

10 Citations (Scopus)

Application of PCSK9 Inhibitors in Practice

Kaufman, T., Warden, B. A., Minnier, J., Miles, J. R., Duell, P., Purnell, J., Wojcik, C., Fazio, S. & Shapiro, M., Jan 4 2019, In : Circulation Research. 124, 1, p. 32-37 6 p.

Research output: Contribution to journal › Article

Subtilisin
Proteins
Insurance
Therapeutics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1 Citation (Scopus)

Bridging the Gap Between Cardiology and Family Medicine

Wojcik, C. & Shapiro, M. D., Aug 27 2019, In : Circulation. 140, 9, p. 709-711 3 p.

Research output: Contribution to journal › Article

Family Practice
Primary Prevention
Cardiology
Cardiovascular Diseases
Cholesterol

Mechanisms and Evidence for Heart Failure Benefits from SGLT2 Inhibitors

Wojcik, C. & Warden, B. A., Sep 14 2019, In : Current cardiology reports. 21, 10, 1 p.

Research output: Contribution to journal › Review article

Sodium-Glucose Transporter 2
Symporters
Heart Failure
Type 2 Diabetes Mellitus
Hospitalization

Translating AHA/ACC cholesterol guidelines into meaningful risk reduction

Wojcik, C. & Shapiro, M., May 1 2019, In : Journal of Family Practice. 68, 4, p. 206-221B

Research output: Contribution to journal › Article

Risk Reduction Behavior
Cholesterol
Guidelines

Co-occurrence of heterozygous CREB3L3 and APOA5 nonsense variants and polygenic risk in a patient with severe hypertriglyceridemia exacerbated by estrogen administration

Wojcik, C., Fazio, S., McIntyre, A. D. & Hegele, R. A., Jan 1 2018, (Accepted/In press) In : Journal of Clinical Lipidology.

Research output: Contribution to journal › Article

Hypertriglyceridemia
Estrogens
Xanthomatosis
Embryo Transfer
Triglycerides